Drug intelligence / Profile preview

Exomega D.E.F.I

Development stage
Unknown
Lead developer
Pierre Fabre
Administration
Topical
01

Overview

Exomega D.E.F.I is a sterile, preservative-free emollient cream developed by A-Derma (a Pierre Fabre brand) specifically for the management of atopic dermatitis and very dry skin. The "D.E.F.I" (Device for Exclusive Formula Integrity) refers to a specialized packaging system that allows the formula to remain sterile without the use of preservatives or parabens. Its primary active ingredient is Rhealba Oat plantlet extract, which possesses anti-inflammatory and soothing properties by inhibiting the release of pro-inflammatory mediators. The product is designed to restore the skin barrier, reduce itching, and decrease the frequency of flare-ups in patients with atopic dermatitis, including infants and children. Clinical studies have demonstrated that twice-daily application significantly improves clinical symptoms, as evidenced by parallel changes in the SCORAD and PO-SCORAD indexes, and reduces the need for rescue topical corticosteroids.

Brand names
Exomega D.E.F.IExomega ControlA-Derma Exomega
Other names
A-Derma Exomega D.E.F.IRhealba Oat plantlet extract emollient

Beyond the preview

Go deeper on Exomega D.E.F.I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exomega D.E.F.I.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call